McLeod DG - Search Results

1

Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.

Gao CL, Dean RC, Pinto A, Mooneyhan R, Connelly RR, McLeod DG, Srivastava S, Moul JW. Gao CL, et al. Among authors: mcleod dg. J Urol. 1999 Apr;161(4):1070-6. J Urol. 1999. PMID: 10081840

2

Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing.

Paquette EL, Sun L, Paquette LR, Connelly R, Mcleod DG, Moul JW. Paquette EL, et al. Among authors: mcleod dg. Urology. 2002 Nov;60(5):756-9. doi: 10.1016/s0090-4295(02)01960-x. Urology. 2002. PMID: 12429290

3

The role of radical prostatectomy in patients with pretreatment prostate-specific antigen > or = 40 ng/mL.

Vanasupa BP, Paquette EL, Wu H, Sun L, McLeod DG, Moul JW. Vanasupa BP, et al. Among authors: mcleod dg. Urol Oncol. 2002 Jul-Aug;7(4):167-72. doi: 10.1016/s1078-1439(02)00187-4. Urol Oncol. 2002. PMID: 12474533

4

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.

Massengill JC, Sun L, Moul JW, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Donahue T. Massengill JC, et al. Among authors: mcleod dg. J Urol. 2003 May;169(5):1670-5. doi: 10.1097/01.ju.0000062674.43964.d0. J Urol. 2003. PMID: 12686805

5

Diagnostic potential of serum proteomic patterns in prostate cancer.

Bañez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, McLeod DG, Moul JW, Srivastava S. Bañez LL, et al. Among authors: mcleod dg. J Urol. 2003 Aug;170(2 Pt 1):442-6. doi: 10.1097/01.ju.0000069431.95404.56. J Urol. 2003. PMID: 12853795 Clinical Trial.

6

Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.

Gao CL, Rawal SK, Sun L, Ali A, Connelly RR, Bañez LL, Sesterhenn IA, McLeod DG, Moul JW, Srivastava S. Gao CL, et al. Among authors: mcleod dg. Clin Cancer Res. 2003 Jul;9(7):2545-50. Clin Cancer Res. 2003. PMID: 12855629

7

Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.

Moul JW, Wu H, Sun L, McLeod DG, Amling C, Donahue T, Kusuda L, Sexton W, O'Reilly K, Hernandez J, Chung A, Soderdahl D. Moul JW, et al. Among authors: mcleod dg. J Urol. 2004 Mar;171(3):1141-7. doi: 10.1097/01.ju.0000113794.34810.d0. J Urol. 2004. PMID: 14767288

8

Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.

Rosner IL, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn IA, McLeod DG, Srivastava S, Petrovics G. Rosner IL, et al. Among authors: mcleod dg. Urology. 2007 Dec;70(6):1225-9. doi: 10.1016/j.urology.2007.09.010. Urology. 2007. PMID: 18158066

9

Clinically detected carcinoma of the prostate treated by radical prostatectomy in a 29-year-old man.

Heidenberg HB, Moul JW, Mostofi FK, McLeod DG. Heidenberg HB, et al. Among authors: mcleod dg. J Urol. 1994 Sep;152(3):966-7. doi: 10.1016/s0022-5347(17)32626-5. J Urol. 1994. PMID: 8051769

10

Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.

Moul JW, Douglas TH, McCarthy WF, McLeod DG. Moul JW, et al. Among authors: mcleod dg. J Urol. 1996 May;155(5):1667-73. J Urol. 1996. PMID: 8627850 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters